| Literature DB >> 35356527 |
Yan-Duo Wang1, Jian Yang2, Qi Li1, Yuan-Yuan Li1, Xiang-Mei Tan1, Si-Yang Yao3, Shu-Bin Niu3, Hui Deng4, Lan-Ping Guo2, Gang Ding1.
Abstract
Seco-sativene sesquiterpenoids are an important member of phytotoxins and plant growth regulators isolated from a narrow spectrum of fungi. In this report, eight seco-sativene sesquiterpenoids (1-8) were first analyzed using the UPLC-Q-TOF-MS/MS technique in positive mode, from which their mass fragmentation pathways were suggested. McLafferty rearrangement, 1,3-rearrangement, and neutral losses were considered to be the main fragmentation patterns for the [M+1]+ ions of 1-8. According to the structural features (of different substitutes at C-1, C-2, and C-13) in compounds 1-8, five subtypes (A-E) of seco-sativene were suggested, from which subtypes A, B/D, and E possessed the diagnostic daughter ions at m/z 175, 189, and 203, respectively, whereas subtype C had the characteristic daughter ion at m/z 187 in the UPLC-Q-TOF-MS/MS profiles. Based on the fragmentation patterns of 1-8, several known compounds (1-8) and two new analogues (9 and 10) were detected in the extract of plant pathogen fungus Bipolaris sorokiniana based on UPLC-Q-TOF-MS/MS analysis, of which 1, 2, 9, and 10 were then isolated and elucidated by NMR spectra. The UPLC-Q-TOF-MS/MS spectra of these two new compounds (9 and 10) were consistent with the fragmentation mechanisms of 1-8. Compound 1 displayed moderate antioxidant activities with IC50 of 0.90 and 1.97 mM for DPPH and ABTS+ scavenging capacity, respectively. The results demonstrated that seco-sativene sesquiterpenoids with the same subtypes possessed the same diagnostic daughter ions in the UPLC-Q-TOF-MS/MS profiles, which could contribute to structural characterization of seco-sativene sesquiterpenoids. Our results also further supported that UPLC-Q-TOF-MS/MS is a powerful and sensitive tool for dereplication and detection of new analogues from crude extracts of different biological origins.Entities:
Keywords: Bipolaris sorokiniana; McLafferty rearrangement; NMR analysis; antioxidant activity; seco-sativene sesquiterpenoids
Year: 2022 PMID: 35356527 PMCID: PMC8959811 DOI: 10.3389/fmicb.2022.807014
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1Structures of seco-sativene sesquiterpenoids (1–10).
NMR spectroscopic data of compounds 9 and 10 in CDCl3.
| Pos. | 9 | 10 | ||||||||
| δH | δC | 1H-1H COSY | HMBC | NOESY | δH | δC | 1H-1H COSY | HMBC | NOESY | |
| 1 | 5.64, s | 127.5, CH | H7 | C3, C6, C12, C13 | 134.8, C | H7, H12, H13 | ||||
| 2 | 141.0, C | H4, H7, H8, H12, H13 | 177.2, C | H4, H7, H8, H12, H13 | ||||||
| 3 | 47.0, C | H1, H4, H5, H7, H8, H12, H13, H14 | 46.9, C | H4, H5, H7, H8, H13, H14 | ||||||
| 4 | 1.36, ddd (13.5, 6.5, 1.5) | 34.5, CH2 | H5 | C2, C3, C5, C6, C8, C13 | 1.57, m | 34.5, CH2 | H15 | C2, C3, C5, C6, C8, C13 | ||
| 1.29, m | ||||||||||
| 5 | 1.67, m | 25.1, CH2 | H4, H6 | C3, C4, C6 | 1.89, m | 25.8, CH2 | H4, H6 | C3, C4, C6, C7 | ||
| 1.11, m | 0.89, m | |||||||||
| 6 | 1.09, m | 43.9, CH | H7 | C4, C7, C10, C11, C13 | H13 | 1.21, m | 43.8, CH | H5, H7, H9 | C9, C10, C11 | H13 |
| 7 | 2.70, s | 42.2, CH | H6, H13 | C3, C5, C6, C9, C13, C14 | H10 | 3.04, s | 41.0, CH | H1, H6, H13 | C1, C2, C3, C5, C6, C14 | H10 |
| 8 | 1.01, s | 18.6, CH3 | C2, C3, C4, C13 | 1.16, s | 18.1, CH3 | C2, C3, C4, C13 | ||||
| 9 | 1.21, dtd (13.5, 6.5, 2.0) | 32.5, CH | H6, H10, H11 | C5, C6, C10, C11 | 1.26, m | 32.4, CH | H6, H10, H11 | C5, C6, C10, C11 | ||
| 10 | 0.93, d (6.5) | 21.2, CH3 | H9, H11 | C6, C9, C11 | H7 | 1.04, d (6.0) | 21.5, CH3 | H9, H11 | C6, C9, C11 | H7 |
| 11 | 0.83, d (6.5) | 20.8, CH3 | H9, H10 | C6, C9, C10 | 0.83, d (6.0) | 20.7, CH3 | H9, H10 | C6, C9, C10 | ||
| 12 | 4.59, d (13.5) | 62.9, CH2 | C1, C2, C3, C2′ | 4.83, dd (18.0, 1.5) | 67.5, CH2 | C1, C2 | ||||
| 4.52, d (13.5) | 4.73, d (18.0) | |||||||||
| 13 | 1.57, dd (8.5, 5.0) | 62.6, CH | H7, H14 | C1, C2, C3, C4, C6, C14 | H6 | 2.16, dd (9.0, 5.5) | 63.5, CH | H7, H14 | C1, C2, C3, C4, C6, C14 | H6 |
| 14 | 3.73, dd (10.5, 5.0) | 63.0, CH2 | H13 | C3, C7, C13 | 4.24, dd (11.0, 5.5) | 64.0, CH | H13 | C3, C7, C13, C2′ | ||
| 3.50, dd (10.5, 8.0) | 3.82, dd (11.0, 9.0) | |||||||||
| 15 | 170.8, C | H12 | ||||||||
| 1′ | 2.07, s | 21.0, CH3 | C12, C2′ | 2.05, s | 21.2, CH3 | C14, C2′ | ||||
| 2′ | 171.2, C | H12, H1′ | 171.2, C | H14, H1′ | ||||||
Elemental constituents of major product ions from [M+Na]+ for compound 1 (subtype A).
| Fragment ion | Formula | Calculated | Observed | Error (PPM) |
| [M+Na]+ | C15H22O4Na | 289.1416 | 289.1412 | −1.4 |
| [M+H-H2O]+ | C15H21O3 | 249.1491 | 249.1499 | +3.2 |
| [M+H-2H2O]+ | C15H19O2 | 231.1385 | 231.1378 | −3.0 |
| [M+H-H2O-CO]+ | C14H21O2 | 221.1542 | 221.1537 | −2.3 |
| [M+H-H2O-HCO2H]+ | C14H19O | 203.1436 | 203.1429 | −3.4 |
| [M+H-H2O-HCO2H-CO]+ | C13H19 | 175.1487 | 175.1479 | −4.6 |
SCHEME 1Possible fragmentation pathway of 1.
Elemental constituents of major product ions from [M+Na]+ for compound 2 (subtype B).
| Fragment ion | Formula | Calculated | Observed | Error (PPM) |
| [M+Na]+ | C15H24O3Na | 275.1623 | 275.1618 | −1.8 |
| [M+H]+ | C15H25O3 | 253.1804 | 253.1797 | −2.8 |
| [M+H-H2O]+ | C15H23O2 | 235.1698 | 235.1703 | +2.1 |
| [M+H-2H2O]+ | C15H21O | 217.1592 | 217.1582 | −4.6 |
| [M+H-2H2O-CO]+ | C14H21 | 189.1643 | 189.1631 | −6.3 |
SCHEME 2Possible fragmentation pathways of 2–4.
SCHEME 3Possible fragmentation pathways of 5 and 6.
Elemental constituents of major product ions from [M+Na]+ for compound 5 (subtype C).
| Fragment ion | Formula | Calculated | Observed | Error (PPM) |
| [M+Na]+ | C21H36O7Na | 423.2359 | 423.2361 | +0.5 |
| [M+H]+ | C21H37O7 | 401.2539 | 401.2535 | −1.0 |
| [M+H-C6H12O6]+ | C15H25O | 221.1905 | 221.1901 | −1.8 |
| [M+H-C6H12O6 -H2O]+ | C15H23 | 203.1800 | 203.1790 | −4.9 |
SCHEME 4Possible fragmentation pathways of 7 and 9.
Elemental constituents of major product ions from [M+Na]+ for compound 7 (subtype D).
| Fragment ion | Formula | Calculated | Observed | Error (PPM) |
| [M+Na]+ | C14H24O2Na | 247.1674 | 247.1668 | −2.4 |
| [M+H]+ | C14H25O2 | 225.1855 | 225.1843 | −5.3 |
| [M+H-H2O]+ | C14H23O | 207.1749 | 207.1754 | +2.4 |
| [M+H-2H2O]+ | C14H21 | 189.1643 | 189.1640 | −1.6 |
SCHEME 5Possible fragmentation pathways of 8 and 10.
Elemental constituents of major product ions from [M+Na]+ for compound 8 (subtype E).
| Fragment ion | Formula | Calculated | Observed | Error (PPM) |
| [M+Na]+ | C15H22O3Na | 273.1467 | 273.1461 | −2.2 |
| [M+H]+ | C15H23O3 | 251.1647 | 251.1664 | +6.8 |
| [M+H-H2O]+ | C15H21O2 | 233.1542 | 233.1536 | −2.6 |
| [M+H-2H2O]+ | C15H19O | 215.1436 | 215.1426 | −4.6 |
| [M+H-H2O-CO]+ | C14H21O | 205.1592 | 205.1585 | −3.4 |
| [M+H-2H2O-CO]+ | C14H19 | 187.1487 | 187.1478 | −4.8 |
FIGURE 2Key 2D-NMR correlations of 9 and 10.
DPPH and ABTS+ scavenging capacity of compounds 1, 2, 9, and 10.
| Compound | DPPH (IC50) | ABTS+ (IC50) |
| 1 | 0.90 ± 0.17 mM | >1 mM |
| 2 | >1 mM | >1 mM |
| 9 | >1 mM | >1 mM |
| 10 | >1 mM | >1 mM |
| Vc | 0.14 ± 0.05 mM | 0.42 ± 0.30 mM |